Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)

ClinicalTrials.gov ID: NCT02371980

Public ClinicalTrials.gov record NCT02371980. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 3:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy of vortioxetine (5, 10, and 20 mg) versus placebo during the first 28 weeks of the 32-week double-blind treatment period in the prevention of relapse in participants with MDD who responded to acute treatment with vortioxetine 10 mg.

Study identification

NCT ID
NCT02371980
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Takeda
Industry
Enrollment
1,106 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 10, 2015 (Actual)
Primary completion
Mar 1, 2019 (Actual)
Completion
Apr 25, 2019 (Actual)
Last update posted
Jan 6, 2021

2015 – 2019

United States locations

U.S. sites
79
U.S. states
28
U.S. cities
71
Facility City State ZIP Site status
NoesisPharma Phoenix Arizona 85032 —
SW Biomedical Research, LLC Tucson Arizona 85712 —
CNS Research Science, Inc. Cerritos California 90703 —
Collaborative Neuroscience Network, LLC Garden Grove California 92845 —
Irvine Center for Clinical Research, Inc. Irvine California 92614 —
Synergy Clinical Research of Escondido Lemon Grove California 91945 —
Pharmacology Research Institute Los Alamitos California 90720 —
Pacific Institute of Medical Research Los Angeles California 90024 —
CNRI - Los Angeles, LLC Pico Rivera California 90660 —
CNRI - San Diego, LLC San Diego California 92102 —
Artemis Institute for Clinical Research, LLC San Diego California 92103 —
University of California San Diego Medical Center San Diego California 92103 —
Pasadena Research Institute San Gabriel California 91776 —
Collaborative Neuroscience Network, LLC Torrance California 90502 —
Research Center for Clinical Studies, Inc. Norwalk Connecticut 06851 —
CNS Clinical Research Group Coral Springs Florida 33067 —
Gulfcoast Medical Research Center, LLC Fort Myers Florida 33912 —
MD Clinical Hallandale Florida 33009 —
Indago Research & Health Center, Inc. Hialeah Florida 33012 —
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32256 —
Meridien Research Maitland Florida 32751 —
Sarkis Clinical Trials - Parent Ocala Florida 34474 —
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801 —
Stedman Clinical Trials, LLC Tampa Florida 33613 —
Janice L. Miller, M.D., PA d/b/a Janus Center for Psychiatric Reseach West Palm Beach Florida 33407 —
Radiant Research, Inc. Atlanta Georgia 30328 —
Atlanta Center for Medical Research Atlanta Georgia 30331 —
iResearch Atlanta, LLC Decatur Georgia 30030 —
Alexian Brothers Center for Psychiatric Research Arlington Heights Illinois 60005 —
Rush St Lukes Presbyterian Medical Center Chicago Illinois 60612 —
Capstone Clinical Research, Inc. Libertyville Illinois 60048 —
Goldpoint Clinical Research, LLC Indianapolis Indiana 46260 —
Buynak Clinical Research Valparaiso Indiana 46383 —
Phoenix Medical Research, Inc. Prairie Village Kansas 66208 —
Heartland Research Associates, LLC Wichita Kansas 67207 —
Lake Charles Clinical Trials, LLC Lake Charles Louisiana 70629 —
Pharmasite Research, Inc. Baltimore Maryland 21208 —
Potomac Grove Clinical Research Center Gaithersburg Maryland 20877 —
Boston Clinical Trials & Medical Research Boston Massachusetts 02131 —
Univ. of Massachussetts Memorial Health Care Systems Worcester Massachusetts 01605-2610 —
Altea Research Institute Las Vegas Nevada 89102 —
Hassman Research Institute Berlin New Jersey 08009 —
Erie County Medical Center Corporation Buffalo New York 14215 —
Neurobehavioral Research, Inc. Cedarhurst New York 11516 —
CNS Research Science, Inc. Jamaica New York 11432 —
Village Clinical Research, Inc. New York New York 10003 —
Manhattan Behavioral Medicine, PLLC New York New York 10022 —
Finger Lakes Clinical Research Rochester New York 14618 —
Montefiore Medical Center PRIME The Bronx New York 10467 —
Duke University Medical Center Durham North Carolina 27710 —
Clinical Trials of America, Inc Hickory North Carolina 28601 —
NorthCoast Clinical Trials, Inc. Beachwood Ohio 44122 —
Patient Priority Clinical Sites, LLC Cincinnati Ohio 45215 —
IPS Research Company Oklahoma City Oklahoma 73103 —
Cutting Edge Research Group, Inc. Oklahoma City Oklahoma 73116 —
Summit Research Network (Oregon) Inc. Portland Oregon 97210 —
Oregon Center for Clinical Investigations, Inc. Portland Oregon 97214 —
Suburban Research Associates Media Pennsylvania 19063 —
Keystone Clinical Studies, LLC Norristown Pennsylvania 19403 —
University of Pennsylvania School of Medicine Philadelphia Pennsylvania 19104 —
Lincoln Research Lincoln Rhode Island 02865 —
Medical University of South Carolina (MUSC) Charleston South Carolina 29401 —
Coastal Carolina Research Center, Inc Mt. Pleasant South Carolina 29464 —
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119 —
FutureSearch Clinical Trials, L.P. Austin Texas 78731 —
BioBehavioral Research of Austin Austin Texas 78759 —
FutureSearch Trials of Dallas, LP Dallas Texas 75231 —
Bayou City Research, Ltd. Houston Texas 77007 —
Houston Clinical Trials, LLC Houston Texas 77098 —
Pillar Clinical Research, LLC Richardson Texas 75080 —
Clinical Trials of Texas, Inc. San Antonio Texas 78229 —
Radiant Research, Inc. Murray Utah 84123 —
Neuropsychiatric Associates Woodstock Vermont 05091 —
University of Virginia Health System Charlottesville Virginia 22903 —
Virginia Commonwealth University Medical Center Richmond Virginia 23298-5054 —
Eastside Therapeutic Resource Everett Washington 98201 —
Summit Research Network (Seattle), LLC Seattle Washington 98104 —
Frontier Institute Spokane Washington 99204 —
Northbrooke Research Center Brown Deer Wisconsin 53223 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02371980, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 6, 2021 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02371980 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →